This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Editors' Note: In reference to “Formal faculty observation and assessment of bedside skills for 3rd-year neurology clerks,” Dr. Sethi and author Dr. Thompson Stone agree that evaluating medical students' neurologic history-taking and examination skills using real patients and then giving feedback is a critical step in combating neurophobia. In reference to “Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache,” Dr. Braillon expands on the safety data available for dihydroergotamine and questions several methodologic points of the study. Authors Robbins and Goadsby address his points.—Megan Alcauskas, MD, and Robert C. Griggs, MD
Editors' Note: In reference to “Formal faculty observation and assessment of bedside skills for 3rd-year neurology clerks,” Dr. Sethi and author Dr. Thompson Stone agree that evaluating medical students' neurologic history-taking and examination skills using real patients and then giving feedback is a critical step in combating neurophobia. In reference to “Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache,” Dr. Braillon expands on the safety data available for dihydroergotamine and questions several methodologic points of the study.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2017 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache
Aprepitant for the management of nausea with inpatient IV dihydroergotamine
A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine
Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome